Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 4
1981 3
1982 2
1983 1
1986 2
1988 1
1991 2
1992 1
1993 2
1995 6
1996 2
1997 5
1998 6
1999 5
2000 10
2001 9
2002 16
2003 13
2004 8
2005 23
2006 13
2007 22
2008 31
2009 31
2010 33
2011 46
2012 35
2013 61
2014 58
2015 71
2016 68
2017 72
2018 87
2019 104
2020 121
2021 165
2022 175
2023 179
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

1,364 results

Results by year

Filters applied: . Clear all
Page 1
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Berdeja JG, Madduri D, Usmani SZ, Jakubowiak A, Agha M, Cohen AD, Stewart AK, Hari P, Htut M, Lesokhin A, Deol A, Munshi NC, O'Donnell E, Avigan D, Singh I, Zudaire E, Yeh TM, Allred AJ, Olyslager Y, Banerjee A, Jackson CC, Goldberg JD, Schecter JM, Deraedt W, Zhuang SH, Infante J, Geng D, Wu X, Carrasco-Alfonso MJ, Akram M, Hossain F, Rizvi S, Fan F, Lin Y, Martin T, Jagannath S. Berdeja JG, et al. Among authors: zhuang sh. Lancet. 2021 Jul 24;398(10297):314-324. doi: 10.1016/S0140-6736(21)00933-8. Epub 2021 Jun 24. Lancet. 2021. PMID: 34175021 Clinical Trial.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. Among authors: zhuang sh. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
Gene editing and its applications in biomedicine.
Li G, Li X, Zhuang S, Wang L, Zhu Y, Chen Y, Sun W, Wu Z, Zhou Z, Chen J, Huang X, Wang J, Li D, Li W, Wang H, Wei W. Li G, et al. Among authors: zhuang s. Sci China Life Sci. 2022 Apr;65(4):660-700. doi: 10.1007/s11427-021-2057-0. Epub 2022 Feb 18. Sci China Life Sci. 2022. PMID: 35235150 Free PMC article. Review.
Circadian disruption and sleep disorders in neurodegeneration.
Shen Y, Lv QK, Xie WY, Gong SY, Zhuang S, Liu JY, Mao CJ, Liu CF. Shen Y, et al. Among authors: zhuang s. Transl Neurodegener. 2023 Feb 13;12(1):8. doi: 10.1186/s40035-023-00340-6. Transl Neurodegener. 2023. PMID: 36782262 Free PMC article. Review.
Structure and dynamics of the EGFR/HER2 heterodimer.
Bai X, Sun P, Wang X, Long C, Liao S, Dang S, Zhuang S, Du Y, Zhang X, Li N, He K, Zhang Z. Bai X, et al. Among authors: zhuang s. Cell Discov. 2023 Feb 13;9(1):18. doi: 10.1038/s41421-023-00523-5. Cell Discov. 2023. PMID: 36781849 Free PMC article.
Single-Atom-Kernelled Nanocluster Catalyst.
Zhuang S, Chen D, Fan W, Yuan J, Liao L, Zhao Y, Li J, Deng H, Yang J, Yang J, Wu Z. Zhuang S, et al. Nano Lett. 2022 Sep 14;22(17):7144-7150. doi: 10.1021/acs.nanolett.2c02290. Epub 2022 Jul 22. Nano Lett. 2022. PMID: 35868014
1,364 results